Jomol Mathew to Risk Factors
This is a "connection" page, showing publications Jomol Mathew has written about Risk Factors.
Connection Strength
0.096
-
George GC, Keller SA, Abner E, Adar S, Alosco ML, Apostolova LG, Bakulski K, Barnes LL, Bateman JR, Batterman S, Beach TG, Bendlin BB, Bennett DA, Betthauser TJ, Brewer J, Buckingham W, Carri?n CI, Chodosh J, Craft S, Croff R, Fabio A, Farias ST, Feldman EL, Goldstein F, Goutman SA, Green-Harris G, Henderson V, Karikari TK, Kofler J, Kucharska-Newton A, Lamar M, Lanata S, Lepping RJ, Lingler J, Lockhart S, Mahnken J, Marsh K, Mathew J, Mecca AP, Meyer O, Miller B, Morris J, Neugroschl J, O'Connor MK, Paulson H, Perrin RJ, Pettigrew C, Pierce A, Powell WR, Pyarajan S, Raji CA, Reiman E, Risacher S, Rissman R, Espinosa PR, Sano M, Saykin AJ, Serrano GE, Singh V, Soldan A, Sultzer D, van Dyck CH, Whitmer R, Wisniewski T, Woltjer R, Yu M, Zhu CW, Kind AJH. The Neighborhoods Study: Examining the social exposome in Alzheimer's disease and related dementias. Alzheimers Dement. 2025 11; 21(11):e70810.
Score: 0.028
-
Ahmed KS, Issaka SM, Marcinak CT, Virani SS, Jaraczewski T, Afshar M, Mayampurath A, Churpek MM, Mathew J, Zafar SN. Machine Learning-Driven Modeling to Predict Postdischarge Venous Thromboembolism After Pancreatectomy for Pancreas Cancer. Ann Surg Oncol. 2025 Jun; 32(6):4085-4093.
Score: 0.027
-
Sun J, Zheng Q, Madhira V, Olex AL, Anzalone AJ, Vinson A, Singh JA, French E, Abraham AG, Mathew J, Safdar N, Agarwal G, Fitzgerald KC, Singh N, Topaloglu U, Chute CG, Mannon RB, Kirk GD, Patel RC. Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US. JAMA Intern Med. 2022 02 01; 182(2):153-162.
Score: 0.022
-
Kapoor A, Amroze A, Vakil F, Crawford S, Der J, Mathew J, Alper E, Yogaratnam D, Javed S, Elhag R, Lin A, Narayanan S, Bartlett D, Nagy A, Shagoury BK, Fischer MA, Mazor KM, Saczynski JS, Ashburner JM, Lopes R, McManus DD. SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation. Circ Cardiovasc Qual Outcomes. 2020 02; 13(2):e005871.
Score: 0.019